{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:46:55Z","timestamp":1790434015766,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.yexmp.2020.104371","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T01:22:17Z","timestamp":1578360137000},"page":"104371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Dexmedetomidine reduces the inflammation and apoptosis of doxorubicin-induced myocardial cells"],"prefix":"10.1016","volume":"113","author":[{"given":"Ying","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinliang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enyou","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2020.104371_bb0005","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jnci\/djp440","article-title":"Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention","volume":"102","author":"Adriana","year":"2010","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.yexmp.2020.104371_bb0010","series-title":"The Effect of the GSK-3\u03b2 Inhibitor, Lithium Chloride on the Apoptosis after Myocardial Ischemia-Reperfusion Injury","author":"Che","year":"2013"},{"key":"10.1016\/j.yexmp.2020.104371_bb0015","article-title":"Effect of dexmedetomidine on myocardial ischemia-reperfusion injury","volume":"8","author":"Chen","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.yexmp.2020.104371_bb0020","first-page":"618","article-title":"Mechanism about exercise preconditioning protect myocardial by means of regulate NLRP3 inflammatory signal pathways on exhaustion exercise rats","volume":"28","author":"Chunli Jiao","year":"2016","journal-title":"Chin. Critical Care Med."},{"key":"10.1016\/j.yexmp.2020.104371_bb0025","series-title":"Disruption of nitric oxide synthase 3 protects against the cardiac injury, dysfunction, and mortality induced by doxorubicin","author":"G Neilan","year":"2007"},{"key":"10.1016\/j.yexmp.2020.104371_bb0030","series-title":"Comprehensive rehabilitation in chronic heart failure","author":"G\u0105siorowski","year":"2013"},{"key":"10.1016\/j.yexmp.2020.104371_bb0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCULATIONAHA.110.953208","article-title":"Impaired macrophage migration inhibitory factor-AMP-activated protein kinase activation and ischemic recovery in the senescent heart","volume":"122","author":"Ma","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.yexmp.2020.104371_bb0040","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biopha.2019.108837","article-title":"Dexmedetomidine preconditioning attenuates ischemia\/reperfusion injury in isolated rat hearts with endothelial dysfunction","volume":"114","author":"He","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.yexmp.2020.104371_bb0045","first-page":"658","article-title":"Effect of TXNIP mediated NLRP3 inflammasome activationon the pathogenesis of preeclampsia","volume":"41","author":"Hua Zhang","year":"2016","journal-title":"J. Chongqing Med. Univ."},{"key":"10.1016\/j.yexmp.2020.104371_bb0050","series-title":"Perioperative Dexmedetomidine Improves Outcomes of Cardiac Surgery","author":"Ji","year":"2013"},{"key":"10.1016\/j.yexmp.2020.104371_bb0055","first-page":"2476","article-title":"Myocardial protective effect and mechanism of dexmedetomidine on myocardial ischemia-reperfusion injury in rats","volume":"17","author":"Jun","year":"2018","journal-title":"J. Clin.Exp. Med."},{"key":"10.1016\/j.yexmp.2020.104371_bb0060","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/00000542-200011000-00030","article-title":"Clinical uses of \u03b12-adrenergic agonists","volume":"93","author":"Kamibayashi","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.yexmp.2020.104371_bb0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mvr.2018.08.006","article-title":"The cardioprotective effect of dexmedetomidine on regional ischemia\/reperfusion injury in type 2 diabetic rat hearts","volume":"123","author":"L D","year":"2019","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.yexmp.2020.104371_bb0070","first-page":"78","article-title":"Taurine - monograph","volume":"6","author":"Listed","year":"2001","journal-title":"Alt. Med. Rev. A J. Clin. Ther."},{"key":"10.1016\/j.yexmp.2020.104371_bb0075","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bbadis.2011.12.013","article-title":"Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia\/reperfusion injury in rat heart","volume":"1822","author":"M","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexmp.2020.104371_bb0080","series-title":"Cardiac-Targeted Expression of Soluble Fas Attenuates Doxorubicin-Induced Cardiotoxicity in Mice","author":"Niu","year":"2009"},{"key":"10.1016\/j.yexmp.2020.104371_bb0085","doi-asserted-by":"crossref","first-page":"E5537","DOI":"10.1073\/pnas.1414665111","article-title":"Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling","volume":"111","author":"Dhingra","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexmp.2020.104371_bb0090","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/1440-1681.12791","article-title":"Dexmedetomidine protects mice against myocardium ischaemic\/reperfusion injury by activating an AMPK\/PI3K\/Akt\/eNOS pathway","volume":"44","author":"Sun","year":"2017","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.yexmp.2020.104371_bb0095","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1159\/000338701","article-title":"Inhibitory effect of p53 Upregulated modulator of apoptosis targeting siRNA on hypoxia\/Reoxygenation-induced Cardiomyocyte apoptosis in rats","volume":"122","author":"Tu","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.yexmp.2020.104371_bb0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12659\/MSMBR.883709","article-title":"Elevated expression of C3G protein in the peri-infarct myocardium of rats","volume":"19","author":"Wang","year":"2013","journal-title":"Med. Sci. Monit. Basic Res."},{"key":"10.1016\/j.yexmp.2020.104371_bb0105","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.yjmcc.2012.03.006","article-title":"Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies","volume":"52","author":"Y","year":"2012","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.yexmp.2020.104371_bb0110","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1093\/cvr\/cvp078","article-title":"A X: Berberine prevents hyperglycemia-induced endothelial injury and enhances vasodilatation via adenosine monophosphate-activated protein kinase and endothelial nitric oxide synthase","volume":"82","author":"Y","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.yexmp.2020.104371_bb0115","series-title":"Effects of Dexmedetomidine Postconditioning on Myocardial Ischemia and the Role of the PI3K\/Akt-Dependent Signaling Pathway in Reperfusion Injury","author":"Yang Cheng","year":"2016"},{"key":"10.1016\/j.yexmp.2020.104371_bb0120","series-title":"K: the central renin-angiotensin system and sympathetic nerve activity in chronic heart failure","author":"Zucker","year":"2014"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480019306719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480019306719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T03:06:33Z","timestamp":1757991993000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480019306719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":24,"alternative-id":["S0014480019306719"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2020.104371","relation":{},"ISSN":["0014-4800"],"issn-type":[{"value":"0014-4800","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dexmedetomidine reduces the inflammation and apoptosis of doxorubicin-induced myocardial cells","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2020.104371","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104371"}}